We chose to keep GLP-1s certainly for diabetes, and we also have it for weight loss as well
Naming the pharmacy up front isnt always a given, especially at this price tiermost compounded clinics decline to disclose which facility actually fills the script

Key points: GLP-1s (glucagon-like peptide-1 receptor agonists) support type 2 diabetes by reducing appetite and supporting weight loss alongside their effects on the pancreas GLP-1-assisted programmes lead to a clinically significant weight loss of 10% or more, which can significantly reduce complications associated with obesity Combining semaglutide with lifestyle interventions leads to significantly more weight loss than lifestyle interventions alone, with 87% of participants losing more than 10% of their body weight Semaglutide is more effective at supporting weight loss than liraglutide Tirzepatide is more effective than semaglutide at reducing weight, with all three doses of tirzepatide leading to more significant weight loss than 1mg of semaglutide The higher doses of tirzepatide (10mg and 15mg) might reduce weight by 5.15kg more than 2mg of semaglutide, while there appears to be no difference between 5mg of tirzepatide and 2mg of semaglutide 3) Side effects and safety All medications have possible side effects, particularly if you live with other health conditions

By incorporating these factors into our model, we aim to provide clinicians with a more accurate and personalized tool for predicting which patients might benefit most from GLP-1 M treatment
Resources We Trust Cleveland Clinic: Should You Microdose GLP-1s
Because of these risks, informed consent is critical